HCAT (Health Catalyst) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 05, 2026)


HCAT Health Catalyst Inc HCAT
44 GF Score
Price $2.08
GF Value $5.02
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Health Catalyst 5-Year Yield-on-Cost %?

Health Catalyst HCAT 44 5-Year Yield-on-Cost % is 0.00 as of Jul. 05, 2026. GuruFocus rates HCAT with a GF Score™ of 44/100 and a GF Value™ of $5.02 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 282 Healthcare Providers & Services companies, Health Catalyst ranks worse than 354609.57% on this metric.

Health Catalyst's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for Health Catalyst's 5-Year Yield-on-Cost % or its related term are showing as below:



HCAT's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.935
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Health Catalyst  (NAS:HCAT) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Health Catalyst 5-Year Yield-on-Cost % Related Terms


HCAT vs SY, AMWL, OPRX: 5-Year Yield-on-Cost % Comparison

For the Health Information Services subindustry, Health Catalyst's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Health Catalyst 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Health Catalyst's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Health Catalyst's 5-Year Yield-on-Cost % falls into.


HCAT
44GF Score
Health Catalyst Inc HCAT
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Health Catalyst 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Health Catalyst is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Health Catalyst (HCAT) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 05, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Health Catalyst and its competitors. According to the industry distribution chart, Health Catalyst ranks #999999 out of 282 companies in the Healthcare Providers & Services industry.
Is Health Catalyst's 5-Year Yield-on-Cost % too high?
Health Catalyst's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Health Catalyst ranks #999999 out of 282 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Health Catalyst has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Health Catalyst's 5-Year Yield-on-Cost % compare to SY and AMWL?
According to the Healthcare Providers & Services industry distribution chart, Health Catalyst ranks #999999 out of 282 companies for 5-Year Yield-on-Cost %. This places Health Catalyst in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.94, based on 282 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Health Catalyst and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health Catalyst's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Catalyst stock overvalued right now?
Based on GuruFocus' analysis, Health Catalyst (HCAT) is currently considered Possible Value Trap. The stock's GF Value™ is $5.02, compared to a current price of $2.08 — trading 58.6% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Health Catalyst's overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Health Catalyst (HCAT), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Health Catalyst (HCAT) Overvalued in 2026?

Based on GuruFocus' analysis, Health Catalyst stock appears to be undervalued. The current stock price of $2.08 is trading 58.6% below its estimated GF Value™ of $5.02. GuruFocus considers Health Catalyst to be Possible Value Trap.

Key valuation signals for HCAT:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $5.02 vs. price of $2.08 (58.6% below fair value)
  • GF Score™: 44/100 with 5 warning signs

No single metric tells the full story. See the HCAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Health Catalyst Business Description

Other Exchanges 2YP:Germany
Address 10897 South River Front Parkway, Suite 300, South Jordan, UT, USA, 84095
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
44GF Score

Get the complete analysis for HCAT

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.08
Price
$5.02
GF Value